BVS Stock Insider Trading NASDAQ:BVS
Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 39.043.
In total, the insiders bought 2 373 042 and sold 851 878 BVS shares in the last 100 trades.
Date | Action | Amount | Person | Type |
Jun 17, 2022 | Buy | 16 648 | Hawkins William A | Restricted Stock Units |
Jun 17, 2022 | Buy | 16 648 | Nohra Guy P | Restricted Stock Units |
Jun 17, 2022 | Buy | 16 648 | Beyer Pat | Restricted Stock Units |
Jun 17, 2022 | Buy | 965 | Beyer Pat | Restricted Stock Units |
Jun 17, 2022 | Buy | 16 648 | Stalnecker Susan M | Restricted Stock Units |
Jun 17, 2022 | Buy | 16 648 | Vizirgianakis Stavros G. | Restricted Stock Units |
Jun 17, 2022 | Buy | 965 | Vizirgianakis Stavros G. | Restricted Stock Units |
Jun 17, 2022 | Buy | 16 648 | Neels Guido J | Restricted Stock Units |
Jun 17, 2022 | Buy | 16 648 | Sutter Martin P | Restricted Stock Units |
Jun 17, 2022 | Buy | 16 648 | Ladone Mary Kay | Restricted Stock Units |
Jun 17, 2022 | Buy | 1 813 | Ladone Mary Kay | Restricted Stock Units |
Jun 17, 2022 | Buy | 16 648 | Mcmurry-heath Michelle | Restricted Stock Units |
Jun 17, 2022 | Buy | 385 | Mcmurry-heath Michelle | Restricted Stock Units |
Jun 16, 2022 | Buy | 965 | Beyer Pat | Class A common stock |
Jun 16, 2022 | Buy | 965 | Vizirgianakis Stavros G. | Class A common stock |
Jun 16, 2022 | Buy | 1 813 | Ladone Mary Kay | Class A common stock |
Jun 16, 2022 | Buy | 385 | Mcmurry-heath Michelle | Class A common stock |
Apr 04, 2022 | Sell | 37 476 | D'adamio Anthony | Restricted Stock Units |
Apr 04, 2022 | Sell | 16 016 | D'adamio Anthony | Class A Common Stock |
Apr 04, 2022 | Sell | 106 485 | Nosenzo John | Restricted Stock Units |
Apr 04, 2022 | Sell | 65 963 | Nosenzo John | Class A Common Stock |
Apr 04, 2022 | Sell | 61 476 | Pavesio Alessandra | Restricted Stock Units |
Apr 04, 2022 | Sell | 32 997 | Pavesio Alessandra | Class A Common Stock |
Apr 04, 2022 | Buy | 223 200 | Singleton Mark Leonard | Stock Option (Right to Buy) |
Apr 04, 2022 | Buy | 74 500 | Singleton Mark Leonard | Restricted Stock Units |
Apr 01, 2022 | Sell | 40 573 | Hawkins William A | Restricted Stock Units |
Apr 01, 2022 | Buy | 40 573 | Hawkins William A | Class A Common Stock |
Apr 01, 2022 | Buy | 37 476 | D'adamio Anthony | Class A Common Stock |
Apr 01, 2022 | Buy | 106 485 | Nosenzo John | Class A Common Stock |
Apr 01, 2022 | Sell | 2 700 | Neels Guido J | Restricted Stock Units |
About Bioventus Inc.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones,... Read more
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.